HIV and the CCR5-Δ32 resistance allele

FEMS Microbiology Letters

Volumn 241, Issue 1, 2004, Pages 1-12

  De Silva, Eric ^a   Stumpf, Michael P H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chemokines; Host virus interactions; Population genetics

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ALLELE; GEOGRAPHIC DISTRIBUTION; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL DOCUMENTATION; MOLECULAR BIOLOGY; NONHUMAN; POPULATION GENETIC PARAMETERS; PRIORITY JOURNAL; SHORT SURVEY; AMINO ACID SEQUENCE; GENETIC SELECTION; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MOLECULAR GENETICS; POPULATION GENETICS; REVIEW;

ALLELES; AMINO ACID SEQUENCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; GENETICS, POPULATION; HIV INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, CCR5; SELECTION (GENETICS);

EID: 8844245596     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2004.09.040     Document Type: Short Survey

References (95)

1. R. Anderson, and R. May Infectious Diseases of Humans 1991 Oxford University Press Oxford
2. M.S. Bartlett Measles periodicity and community size J. Roy. Statist. Soc. 120 1957 48 70
3. L.L. Cavalli-Sforza, and W.F. Bodmer The Genetics of Human Populations 1999 Dover USA
4. S. Mead, M.P.H. Stumpf, J. Whitfield, J.A. Beck, M. Poulter, T. Campbell, J.B. Uphill, D. Goldstein, M. Alpers, E.M.C. Fisher, and J. Collinge Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics Science 300 5619 2003 640 643 (historical article)
5. D. Meyer, and G. Thomson How selection shapes variation of the human major histocompatibility complex: a review Ann. Hum. Genet. 65 Pt. 1 2001 1 26
6. A.M. Vine, A.D. Witkover, A.L. Lloyd, K.J.M. Jeffery, A. Siddiqui, S.E.F. Marshall, M. Bunce, N. Eiraku, S. Izumo, K. Usuku, M. Osame, and C.R.M. Bangham Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis J. Infect. Dis. 186 7 2002 932 939
7. S. Mummidi, S.S. Ahuja, E. Gonzalez, S.A. Anderson, E.N. Santiago, K.T. Stephan, F.E. Craig, P. O'Connell, V. Tryon, R.A. Clark, M.J. Dolan, and S.K. Ahuja Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression Nat. Med. 4 7 1998 786 793
8. E.A. Berger, P.M. Murphy, and J.M. Farber Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease Annu. Rev. Immunol. 17 1999 657 700
9. B.J. Rollins Chemokines Blood 90 3 1997 909 928
10. T.N. Wells, C.A. Power, and A.E. Proudfoot Definition, function and pathophysiological significance of chemokine receptors Trends Pharmacol. Sci. 19 9 1998 376 380
11. M. Dean, M. Carrington, and S.J. O'Brien Balanced polymorphism selected by genetic versus infectious human disease Annu. Rev. Genom. Hum. Genet. 3 2002 263 292
12. S.J. O'Brien, and J.P. Moore The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS Immunol. Rev. 177 2000 99 111
13. S. Mahalingam, and G. Karupiah Chemokines and chemokine receptors in infectious diseases Immunol. Cell Biol. 77 6 1999 469 475
14. C. Murdoch, and A. Finn Chemokine receptors and their role in inflammation and infectious diseases Blood 95 10 2000 3032 3043
15. V. Sharma, and S.L. Lorey Autocrine role of macrophage inflammatory protein-1 beta in human T-cell lymphotropic virus type-I tax-transfected Jurkat T-cells Biochem. Biophys. Res. Commun. 287 4 2001 910 913
16. T. Kielian Microglia and chemokines in infectious diseases of the nervous system: views and reviews Front. Biosci. 9 2004 732 750
17. B. Homey, and E. Bunemann Chemokines and inflammatory skin diseases Ernst. Schering Res. Found Workshop 45 2004 69 83
18. Y. Sheikine, and G.K. Hansson Chemokines and atherosclerosis Ann. Med. 36 2 2004 98 118
19. M. Carrington, T. Kissner, B. Gerrard, S. Ivanov, S.J. O'Brien, and M. Dean Novel alleles of the chemokine-receptor gene CCR5 Am. J. Hum. Genet. 61 6 1997 1261 1267
20. Z.L. Brumme, K.J. Chan, W. Dong, R. Hogg, M.V. O'Shaughnessy, J.S. Montaner, and P.R. Harrigan CCR5Delta32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response AIDS 15 17 2001 2259 2266
21. M. Carrington, M. Dean, M.P. Martin, and S.J. O'Brien Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences Hum. Mol. Genet. 8 10 1999 1939 1945
22. S. Mummidi, M. Bamshad, S.S. Ahuja, E. Gonzalez, P.M. Feuillet, K. Begum, M.C. Galvis, V. Kostecki, A.J. Valente, K.K. Murthy, L. Haro, M.J. Dolan, J.S. Allan, and S.K. Ahuja Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus J. Biol. Chem. 275 25 2000 18946 18961
23. E. Gonzalez, R. Dhanda, M. Bamshad, S. Mummidi, R. Geevarghese, G. Catano, S.A. Anderson, E.A. Walter, K.T. Stephan, M.F. Hammer, A. Mangano, L. Sen, R.A. Clark, S.S. Ahuja, M.J. Dolan, and S.K. Ahuja Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic Proc. Natl. Acad. Sci. USA 98 9 2001 5199 5204
24. J.M. McNicholl, D.K. Smith, S.H. Qari, and T. Hodge Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele Emerg. Infect. Dis. 3 3 1997 261 271
25. J.C. Stephens, D.E. Reich, D.B. Goldstein, H.D. Shin, M.W. Smith, M. Carrington, C. Winkler, G.A. Huttley, R. Allikmets, L. Schriml, B. Gerrard, M. Malasky, M.D. Ramos, S. Morlot, M. Tzetis, C. Oddoux, F.S. diGiovine, G. Nasioulas, D. Chandler, M. Aseev, M. Hanson, L. Kalaydjieva, D. Glavac, P. Gasparini, and M. Dean Dating the origin of the CCR5-Δ32 AIDS-resistance allele by the coalescence of haplotypes Am. J. Hum. Genet. 62 6 1998 1507 1515
26. Y. Huang, W.A. Paxton, S.M. Wolinsky, A.U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N.R. Landau, J. Phair, D.D. Ho, and R.A. Koup The role of a mutant CCR5 allele in HIV-1 transmission and disease progression Nat. Med. 2 11 1996 1240 1243
27. S.J. O'Brien, and M. Dean In search of AIDS-resistance genes Sci. Am. 277 3 1997 44 51
28. A. Dalgleish, and R. Weiss HIV and the New Viruses 2nd ed. 1999 Academic Press New York
29. F. Shaheen, and R.G. Collman Co-receptor antagonists as HIV-1 entry inhibitors Curr. Opin. Infect. Dis. 17 1 2004 7 16
30. M. Benkirane, D.Y. Jin, R.F. Chun, R.A. Koup, and K.T. Jeang Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by CCR5Δ32 J. Biol. Chem. 272 49 1997 30603 30606
31. M. Dean, M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, and S.J. O'Brien Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study Science 273 5283 1996 1856 1862
32. L. Agrawal, X. Lu, J. Qingwen, Z. VanHorn-Ali, I.V. Nicolescu, D.H. McDermott, P.M. Murphy, and G. Alkhatib Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells J. Virol. 78 5 2004 2277 2287
33. P.C. Guenthner, R.C. Hershow, R.B. Lal, and C.S. Dezzutti Effects of human T-lymphotropic virus type II on human immunodeficiency virus type 1 phenotypic evolution Arch. Virol. 146 8 2001 1617 1622
34. L. Ometto, M. Zanchetta, A. Cabrelle, G. Esposito, M. Mainardi, L. Chieco-Bianchi, and A. DeRossi Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene AIDS Res. Hum. Retroviruses 15 16 1999 1441 1452
35. F. Libert, P. Cochaux, G. Beckman, M. Samson, M. Aksenova, A. Cao, A. Czeizel, M. Claustres, C. dela Rua, M. Ferrari, C. Ferrec, G. Glover, B. Grinde, S. Guran, V. Kucinskas, J. Lavinha, B. Mercier, G. Ogur, L. Peltonen, C. Rosatelli, M. Schwartz, V. Spitsyn, L. Timar, L. Beckman, and G. Vassart The CCR-Δ5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe Hum. Mol. Genet. 7 3 1998 399 406
36. M.W. Smith, M. Dean, M. Carrington, C. Winkler, G.A. Huttley, D.A. Lomb, J.J. Goedert, T.R. O'Brien, L.P. Jacobson, R. Kaslow, S. Buchbinder, E. Vittinghoff, D. Vlahov, K. Hoots, M.W. Hilgartner, and S.J. O'Brien Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study Science 277 5328 1997 959 965
37. D.H. McDermott, M.J. Beecroft, C.A. Kleeberger, F.M. Al-Sharif, W.E. Ollier, P.A. Zimmerman, B.A. Boatin, S.F. Leitman, R. Detels, A.H. Hajeer, and P.M. Murphy Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study AIDS 14 17 2000 2671 2678
38. R. Grimaldi, N. Shindo, A.X. Acosta, I. Dourado, C. Brites, O. de Melo Carvalho, I. Brito, D.C. Bou-Habib, and B. Galvao-Castro Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection Hum. Genet. 111 1 2002 102 104
39. C. Williamson, S.A. Loubser, B. Brice, G. Joubert, T. Smit, R. Thomas, M. Visagie, M. Cooper, and E. vander Ryst Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in South African populations AIDS 14 4 2000 449 451
40. A. Papa, E. Papadimitriou, G. Adwan, J.P. Clewley, N. Malissiovas, I. Ntoutsos, S. Alexiou, and A. Antoniadis HIV-1 co-receptor CCR5 and CCR2 mutations among Greeks FEMS Immunol. Med. Microbiol. 28 1 2000 87 89
41. A. Morner, A. Bjorndal, A.-C. Leandersson, J. Albert, E. Bjorling, and M. Jansson CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates AIDS Res. Hum. Retroviruses 18 3 2002 193 200
42. S. Manes, E. Mira, R. Colomer, S. Montero, L.M. Real, C. Gomez-Mouton, S. Jimenez-Baranda, A. Garzon, R.A. Lacalle, K. Harshman, A. Ruiz, and C. Martinez-A CCR5 expression influences the progression of human breast cancer in a p53-dependent manner J. Exp. Med. 198 9 2003 1381 1389
43. M. Mettimano, M.L. Specchia, A. Ianni, D. Arzani, G. Ricciardi, L. Savi, and V. Romano-Spica CCR5 and CCR2 gene polymorphisms in hypertensive patients Br. J. Biomed. Sci. 60 1 2003 19 21
44. P. Srivastava, P.J. Helms, D. Stewart, M. Main, and G. Russell Association of CCR5Δ32 with reduced risk of childhood but not adult asthma Thorax 58 3 2003 222 226
45. C. Szalai, A. Bojszko, G. Beko, and A. Falus Prevalence of CCR5Δ32 in allergic diseases Lancet 355 9197 2000 66 (clinical trial)
46. A. Nagy, G.T. Kozma, A. Bojszko, D. Krikovszky, A. Falus, and C. Szalai No association between asthma or allergy and the CCR5Δ32 mutation Arch. Dis. Child 86 6 2002 426
47. P. Skendros, P. Boura, N. Tsantas, P. Debre, and I. Theodorou Frequency analysis of the CCR5Δ32 mutation in patients with brucellosis Scand. J. Infect. Dis. 34 12 2002 944 946
48. K. Promrat, D.H. McDermott, C.M. Gonzalez, D.E. Kleiner, D.E. Koziol, M. Lessie, M. Merrell, A. Soza, T. Heller, M. Ghany, Y. Park, H.J. Alter, J.H. Hoofnagle, P.M. Murphy, and T.J. Liang Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C Gastroenterology 124 2 2003 352 360
49. A.K.N. Iversen, C.B. Christiansen, J. Attermann, J. Eugen-Olsen, S. Schulman, E. Berntorp, J. Ingerslev, L. Fugger, E. Scheibel, L. Tengborn, J. Gerstoft, E. Dickmeiss, A. Svejgaard, and P. Skinhoj Limited protective effect of the CCR5Δ32/CCR5Δ32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus J. Infect. Dis. 187 2 2003 215 225
50. J.A.B. Chies, and M.H. Hutz High frequency of the CCR5Δ32 variant among individuals from an admixed Brazilian population with sickle cell anemia Braz. J. Med. Biol. Res. 36 1 2003 71 75
51. B. Schroppel, M. Fischereder, R. Ashkar, M. Lin, B.K. Kramer, B. Mardera, T. Schiano, and B. Murphy The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation Am. J. Transplant. 2 7 2002 640 645
52. K. Schreiber, A.B. Otura, L.P. Ryder, H.O. Madsen, O.S. Jorgensen, A. Svejgaard, and P.S. Sorensen Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E) Mult. Scler. 8 4 2002 295 298
53. L.F. Barcellos, A.M. Schito, J.B. Rimmler, E. Vittinghoff, A. Shih, R. Lincoln, S. Callier, M.K. Elkins, D.E. Goodkin, J.L. Haines, M.A. Pericak-Vance, S.L. Hauser, and J.R. Oksenberg CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group Immunogenetics 51 4-5 2000 281 288
54. M. Petrek, A. Gibejova, J. Drabek, F. Mrazek, V. Kolek, E. Weigl, and R.M. duBois CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis Immunol. Lett. 80 3 2002 189 193
55. M. Petrek, J. Drabek, V. Kolek, J. Zlamal, K.I. Welsh, M. Bunce, E. Weigl, and R. DuBois CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis Am. J. Respir. Crit. Care Med. 162 3 Pt 1 2000 1000 1003
56. J.E. Calzada, A. Nieto, Y. Beraun, and J. Martin Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy Tissue Antigens 58 3 2001 154 158
57. L. Ometto, R. Bertorelle, M. Mainardi, M. Zanchetta, S. Tognazzo, O. Rampon, E. Ruga, L. Chieco-Bianchi, and A. DeRossi Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children J. Infect. Dis. 183 5 2001 814 818
58. C.F. Barroga, C. Raskino, M.C. Fangon, P.E. Palumbo, C.J. Baker, J.A. Englund, and S.A. Spector The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment J. Infect. Dis. 182 2 2000 413 419 (clinical trial)
59. S.S. Bakshi, L. Zhang, D. Ho, S. Than, and S.G. Pahwa Distribution of CCR5-Δ32 in human immunodeficiency virus-infected children and its relationship to disease course Clin. Diagn. Lab. Immunol. 5 1 1998 38 40 (case reports)
60. M. Misrahi, J.P. Teglas, N. N'Go, M. Burgard, M.J. Mayaux, C. Rouzioux, J.F. Delfraissy, and S. Blanche CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group JAMA 279 4 1998 277 280
61. C. Szalai, J. Duba, Z. Prohaszka, T. Szabo, B. Nagy, L. Horvath, and A. Csaszar Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients Atherosclerosis 158 1 2001 233 239
62. M. Fischereder, B. Luckow, B. Hocher, R.P. Wuthrich, U. Rothenpieler, H. Schneeberger, U. Panzer, R.A. Stahl, I.A. Hauser, K. Budde, H. Neumayer, B.K. Kramer, W. Land, and D. Schlondorff CC chemokine receptor 5 and renal-transplant survival Lancet 357 9270 2001 1758 1761
63. H. Herfarth, B. Pollok-Kopp, M. Goke, A. Press, and M. Oppermann Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn's disease Immunol. Lett. 77 2 2001 113 117
64. A. Rector, S. Vermeire, I. Thoelen, E. Keyaerts, F. Struyf, R. Vlietinck, P. Rutgeerts, and M. VanRanst Analysis of the CC chemokine receptor 5 (CCR5) Δ-32 polymorphism in inflammatory bowel disease Hum. Genet. 108 3 2001 190 193
65. V. Zachar, V. Zacharova, T. Fink, R.A. Thomas, B.R. King, P. Ebbesen, T.B. Jones, and A.S. Goustin Genetic analysis reveals ongoing HIV type 1 evolution in infected human placental trophoblast AIDS Res. Hum. Retroviruses 15 18 1999 1673 1683
66. C. Szalai, A. Csaszar, A. Czinner, T. Szabo, P. Panczel, L. Madacsy, and A. Falus Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus Pediatr. Res. 46 1 1999 82 84
67. W. Klitz, C. Brautbar, A.M. Schito, L.F. Barcellos, and J.R. Oksenberg Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish and Northern European population samples Hum. Immunol. 62 5 2001 530 538
68. G. Lucotte Distribution of the CCR5 gene32-basepair deletion in West Europe. A hypothesis about the possible dispersion of the mutation by the Vikings in historical times Hum. Immunol. 62 9 2001 933 936
69. M. Kimura The Neutral Theory of Molecular Evolution 1983 Cambridge University Press Cambridge (MA)
70. D. Hartl, and A. Clark Principles of Population Genetics 1997 Sinauer Associates Sunder
71. C. Desgranges, P. Carvajal, A. Afani, M.A. Guzman, A. Sasco, and C. Sepulveda Frequency of CCR5 gene 32-basepair deletion in Chilean HIV-1 infected and non-infected individuals Immunol. Lett. 76 2 2001 115 117
72. F. Wang, and D. Liu Polymorphism of human alleles associated with genetic resistance against HIV-1 infection and its implications Zhonghua Yi Xue Yi Chuan Xue Za Zhi 17 4 2000 285 287
73. M. Stumpf, and H. Wilkinson-Herbots Allelic histories: positive selection on a HIV-resistance allele Trends Ecol. Evolution 19 14 2004 166 168
74. C. Blanpain, B. Lee, M. Tackoen, B. Puffer, A. Boom, F. Libert, M. Sharron, V. Wittamer, G. Vassart, R.W. Doms, and M. Parmentier Multiple nonfunctional alleles of CCR5 are frequent in various human populations Blood 96 5 2000 1638 1645
75. C. Capelli, J.F. Wilson, M. Richards, M.P. Stumpf, F. Gratrix, S. Oppenheimer, P. Underhill, V.L. Pascali, T.M. Ko, and D.B. Goldstein A predominantly indigenous paternal heritage for the Austronesian-speaking peoples of insular Southeast Asia and Oceania Am. J. Hum. Genet. 68 2 2001 432 443
76. N. Risch, D. deLeon, L. Ozelius, P. Kramer, L. Almasy, B. Singer, S. Fahn, X. Breakefield, and S. Bressman Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population Nat. Genet. 9 2 1995 152 159 (historical article)
77. C.A. Edmonds, A.S. Lillie, and L.L. Cavalli-Sforza Mutations arising in the wave front of an expanding population Proc. Natl. Acad. Sci. USA 101 4 2004 975 979
78. P. Schliekelman, C. Garner, and M. Slatkin Natural selection and resistance to HIV Nature 411 6837 2001 545 546
79. R.E. Lenski Evolution of plague virulence Nature 334 6182 1988 473 474 news
80. A.P. Galvani, and M. Slatkin Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele Proc. Natl. Acad. Sci. USA 100 25 2003 15276 15279
81. A.S. Lalani, J. Masters, W. Zeng, J. Barrett, R. Pannu, H. Everett, C.W. Arendt, and G. McFadden Use of chemokine receptors by poxviruses Science 286 5446 1999 1968 1971
82. A. Carfi, C.A. Smith, P.J. Smolak, J. McGrew, and D.C. Wiley Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus Proc. Natl. Acad. Sci. USA 96 22 1999 12379 12383
83. B.T. Seet, J.B. Johnston, C.R. Brunetti, J.W. Barrett, H. Everett, C. Cameron, J. Sypula, S.H. Nazarian, A. Lucas, and G. McFadden Poxviruses and immune evasion Annu. Rev. Immunol. 21 2003 377 423
84. P.C. Reading, J.A. Symons, and G.L. Smith A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection J. Immunol. 170 3 2003 1435 1442
85. J. Mecsas, G. Franklin, W.A. Kuziel, R.R. Brubaker, S. Falkow, and D.E. Mosier Evolutionary genetics: CCR5 mutation and plague protection Nature 427 6975 2004 606
86. B. Postic, J.A. Horvath, and R. Talwani Antiviral treatment of human immunodeficiency virus infection: update for 2003 JSC Med. Assoc. 99 6 2003 148 153
87. M. Flepp, V. Schiffer, R. Weber, and B. Hirschel Modern anti-HIV therapy Swiss. Med. Wkly. 131 15-16 2001 207 213
88. P. Poignard, E.O. Saphire, P.W. Parren, and D.R. Burton gp120: Biologic aspects of structural features Annu. Rev. Immunol. 19 2001 253 274
89. C.D. Rizzuto, R. Wyatt, N. Hernandez-Ramos, Y. Sun, P.D. Kwong, W.A. Hendrickson, and J. Sodroski A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding Science 280 5371 1998 1949 1953
90. M. Pierdominici, A. Giovannetti, F. Ensoli, F. Mazzetta, M. Marziali, M.R. DeCristofaro, D. Santini-Muratori, W. Leti, and F. Aiuti Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy J. Acquir. Immune Defic. Syndr. 29 2 2002 122 131
91. O.O. Yang, E.A. Garcia-Zepeda, B.D. Walker, and A.D. Luster Monocyte chemoattractant protein-2 (CC chemokine ligand 8) inhibits replication of human immunodeficiency virus type 1 via CC chemokine receptor 5 J. Infect. Dis. 185 8 2002 1174 1178
92. A. Trkola, T. Dragic, J. Arthos, J.M. Binley, W.C. Olson, G.P. Allaway, C. Cheng-Mayer, J. Robinson, P.J. Maddon, and J.P. Moore CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 Nature 384 6605 1996 184 187
93. C. Butticaz, A. Ciuffi, M. Munoz, J. Thomas, A. Bridge, S. Pebernard, R. Iggo, P. Meylan, and A. Telenti Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression Antivir. Ther. 8 5 2003 373 377
94. J.D. Chen, X. Bai, A.G. Yang, Y. Cong, and S.Y. Chen Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy Nat. Med. 3 10 1997 1110 1116
95. B.T. Grenfell, O.G. Pybus, J.R. Gog, J.L.N. Wood, J.M. Daly, J.A. Mumford, and E.C. Holmes Unifying the epidemiological and evolutionary dynamics of pathogens Science 303 5656 2004 327 332